Cargando…
Topically Applied Resiquimod versus Imiquimod as a Potential Adjuvant in Melanoma Treatment
Melanoma is the most lethal form of skin cancer and surgery remains the preferred and most effective treatment. Nevertheless, there are cases where surgery is not a viable method and alternative treatments are therefore adopted. One such treatment that has been tested is topical 5% imiquimod (IMQ) c...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9611754/ https://www.ncbi.nlm.nih.gov/pubmed/36297510 http://dx.doi.org/10.3390/pharmaceutics14102076 |